Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
0.6700
-0.0070 (-1.03%)
Aug 6, 2026, 9:43 AM EDT - Market open
Inovio Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Inovio Pharmaceuticals stock has a consensus rating of "Hold" and an average price target of $2.77. The average 1-year stock price forecast is 313.43% higher than the current stock price, while the lowest is $1.80 (+168.66%) and the highest is $4.00 (+497.01%).
Price Target: $2.77 (+313.43%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Inovio Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 0 | 0 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $6 → $4 | Buy | Reiterates | $6 → $4 | +497.01% | Aug 3, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $2.5 | Hold | Reiterates | $2.5 | +273.13% | Jun 1, 2026 |
Financial Forecast
Revenue This Year
666.67K
from 65.34K
Increased by 920.26%
Revenue Next Year
51.31M
from 666.67K
Increased by 7,595.76%
EPS This Year
-1.14
from -1.82
EPS Next Year
-0.46
from -1.14
EPS and Forward PE are based on non-GAAP adjusted numbers.